| Code | Description | Claims | Beneficiaries | Total Paid |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
69,829 |
28,890 |
$1.40M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
65,208 |
61,215 |
$1.23M |
| 87481 |
|
52,685 |
27,469 |
$1.11M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
64,857 |
60,922 |
$1.09M |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
56,393 |
52,917 |
$962K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
3,925 |
3,331 |
$719K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
43,880 |
41,723 |
$551K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
31,969 |
30,329 |
$516K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
2,776 |
2,094 |
$387K |
| 87511 |
|
29,856 |
27,618 |
$320K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,396 |
4,896 |
$259K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
5,482 |
4,486 |
$254K |
| 81443 |
|
345 |
307 |
$223K |
| 87653 |
|
8,518 |
8,165 |
$163K |
| 88141 |
|
8,684 |
8,227 |
$108K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
4,814 |
4,034 |
$54K |
| 87625 |
|
3,115 |
2,965 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,920 |
1,645 |
$41K |
| 88142 |
|
4,044 |
3,825 |
$37K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,139 |
956 |
$36K |
| 87529 |
|
945 |
822 |
$32K |
| 87563 |
|
1,769 |
1,575 |
$29K |
| 88112 |
|
3,064 |
2,832 |
$25K |
| 88342 |
|
270 |
237 |
$10K |
| 88377 |
|
67 |
65 |
$10K |
| 87640 |
|
318 |
304 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
774 |
725 |
$7K |
| 81329 |
|
2,502 |
2,031 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
864 |
824 |
$4K |
| 87660 |
|
211 |
187 |
$4K |
| 81243 |
|
2,792 |
2,105 |
$4K |
| 87510 |
|
211 |
187 |
$3K |
| 87480 |
|
215 |
190 |
$3K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
821 |
701 |
$3K |
| 81257 |
|
1,235 |
887 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,437 |
1,318 |
$3K |
| 80081 |
|
315 |
301 |
$3K |
| 86780 |
|
732 |
706 |
$3K |
| 81514 |
|
90 |
90 |
$3K |
| 88307 |
|
14 |
14 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
221 |
210 |
$2K |
| 88341 |
|
57 |
51 |
$2K |
| 81250 |
|
1,198 |
856 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
9,199 |
7,545 |
$2K |
| 83020 |
|
381 |
251 |
$2K |
| 86803 |
|
401 |
389 |
$2K |
| 81255 |
|
1,197 |
855 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,084 |
1,034 |
$1K |
| 81251 |
|
1,193 |
855 |
$1K |
| 86696 |
|
208 |
196 |
$1K |
| 84439 |
|
340 |
321 |
$1K |
| 87340 |
|
233 |
225 |
$1K |
| 80053 |
Comprehensive metabolic panel |
422 |
376 |
$1K |
| 80055 |
|
94 |
86 |
$1K |
| 82951 |
|
349 |
295 |
$957.87 |
| 86762 |
|
177 |
164 |
$837.04 |
| 85041 |
|
847 |
577 |
$695.31 |
| 88120 |
|
14 |
12 |
$662.06 |
| 82728 |
|
99 |
98 |
$629.39 |
| 80074 |
|
40 |
36 |
$612.53 |
| 80061 |
Lipid panel |
112 |
107 |
$592.49 |
| G0416 |
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method |
26 |
24 |
$569.83 |
| 88313 |
|
14 |
14 |
$548.97 |
| 84153 |
|
146 |
146 |
$502.47 |
| 80050 |
General health panel |
14 |
14 |
$455.46 |
| 84702 |
|
72 |
50 |
$428.59 |
| 86703 |
|
316 |
303 |
$384.99 |
| 83525 |
|
83 |
82 |
$346.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
184 |
176 |
$283.15 |
| 88304 |
|
12 |
12 |
$237.16 |
| 86592 |
|
474 |
465 |
$214.85 |
| 87088 |
|
74 |
68 |
$196.25 |
| 83001 |
|
40 |
39 |
$195.39 |
| 81001 |
|
161 |
146 |
$175.98 |
| 82950 |
|
231 |
223 |
$168.58 |
| 87186 |
|
57 |
53 |
$152.99 |
| 87070 |
|
32 |
32 |
$132.03 |
| 87341 |
|
45 |
43 |
$125.96 |
| 81401 |
|
298 |
214 |
$115.31 |
| 83002 |
|
14 |
14 |
$113.73 |
| 87077 |
|
50 |
46 |
$108.23 |
| 88302 |
|
13 |
13 |
$103.48 |
| 84146 |
|
14 |
14 |
$102.72 |
| 87081 |
|
152 |
148 |
$69.09 |
| 87015 |
|
18 |
18 |
$69.07 |
| 86140 |
|
30 |
29 |
$67.95 |
| 86704 |
|
13 |
13 |
$65.04 |
| 85027 |
|
27 |
27 |
$31.46 |
| 82947 |
|
18 |
18 |
$9.90 |
| 81330 |
|
507 |
269 |
$0.00 |
| 81209 |
|
503 |
267 |
$0.00 |
| 81242 |
|
503 |
267 |
$0.00 |
| 81400 |
|
509 |
269 |
$0.00 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
54 |
52 |
$0.00 |
| 81200 |
|
503 |
267 |
$0.00 |
| 81479 |
Unlisted molecular pathology procedure |
3,170 |
655 |
$0.00 |
| 81422 |
|
82 |
58 |
$0.00 |
| 81205 |
|
515 |
274 |
$0.00 |
| 81260 |
|
504 |
268 |
$0.00 |
| 81290 |
|
505 |
269 |
$0.00 |